Predictive Oncology Inc
POAI
View Detailed Chart
5.950USD
0.000
Close 12/24, 13:00（ET）Quotes delayed by 15 min
4.56MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
-4.80%
6 Months
-54.92%
Year to Date
-51.63%
1 Year
-46.83%
View Detailed Chart
TradingKey Stock Score of Predictive Oncology Inc
Currency: USD Updated: 2025-12-11Key Insights
Predictive Oncology Inc's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 229/405 in the Biotechnology & Medical Research industry.Institutional ownership is low.Over the past month, multiple analysts have rated it as , with the highest price target at 3.00.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Predictive Oncology Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
3.000
Target Price
+251.62%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Predictive Oncology Inc Highlights
StrengthsRisks
Predictive Oncology Inc. is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.62M.
Overvalued
The company’s latest PE is -0.04, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 7.39K shares, decreasing 77.87% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.
Predictive Oncology Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Predictive Oncology Inc Info
Predictive Oncology Inc. is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Ticker SymbolPOAI
CompanyPredictive Oncology Inc
CEOVennare (Raymond F)
Websitehttps://predictive-oncology.com/
FAQs
What is the current price of Predictive Oncology Inc (POAI)?
The current price of Predictive Oncology Inc (POAI) is 5.950.
What is the symbol of Predictive Oncology Inc?
The ticker symbol of Predictive Oncology Inc is POAI.
What is the 52-week high of Predictive Oncology Inc?
The 52-week high of Predictive Oncology Inc is 45.900.
What is the 52-week low of Predictive Oncology Inc?
The 52-week low of Predictive Oncology Inc is 3.880.
What is the market capitalization of Predictive Oncology Inc?
The market capitalization of Predictive Oncology Inc is 4.56M.
What is the net income of Predictive Oncology Inc?
The net income of Predictive Oncology Inc is -12.66M.
Is Predictive Oncology Inc (POAI) currently rated as Buy, Hold, or Sell?
According to analysts, Predictive Oncology Inc (POAI) has an overall rating of --, with a price target of 3.000.
What is the Earnings Per Share (EPS TTM) of Predictive Oncology Inc (POAI)?
The Earnings Per Share (EPS TTM) of Predictive Oncology Inc (POAI) is -139.762.
Related Instruments
+0.41%
+0.94%
+0.51%
+0.34%
-0.17%
+1.42%
+0.75%
+1.80%
+0.38%
+0.66%
+0.08%
+0.82%
+0.81%
+0.08%
+0.23%
-0.05%
-0.19%
0.00%
+1.54%
+0.50%
